Wilbert Willems โ€” investor profile photo

Wilbert Willems

Shareholder bij CryoSol-World

๐Ÿ“ The Hague, South Holland, Netherlands๐Ÿ”„ Updated November 2026๐Ÿ’ผ 5 investments๐Ÿ“… 35 years investing๐Ÿ—“ Last invested Apr 2018
Operator-angel๐ŸŒ Netherlands
5
Total investments
1
Early stage
1
Mid stage
0
Late stage
35y
Years active

Portfolio

2 investments ยท sorted by recency
All investments
Early stage
Mid stage
Late stage
Shareholder
Apr 2018
CryoSol-World (CryoSol) is an innovative high-tech company that aims to become the global leader in sample preparation technology for cryo-EM. At CryoSol, we believe innovation in sample preparation technology is of vital importance for structural biologists to advance their cryo-electron microscopy (cryo-EM) results. This is why our focus is on controllable and reproducible solutions. Our unique VitroJet solution helps structural biologists unravel the mysteries of proteins: the molecules of life. Proteins play a key role in developing life-changing medicines, vaccines, and cures for diseases, like COVID-19 and cancer. It will take a lot of research, knowledge-sharing and hard work to get there. That is why we are driven to help structural biologists with their challenges to vitrify samples at high throughput. We are passionate about science and we like to push the boundaries of technology. We are a flexible, open-minded team that thrives on sharing knowledge. We value the contributions of customers, partners, and colleagues around the world. Together, we can help life scientists in their quest to achieve more groundbreaking research discoveries that will make a lasting difference in life. Because two achieve more.
shareholder
1999
IBIS Technologies is a leader in innovative label-free analytical systems for profiling biomolecular interactions using Surface Plasmon Resonance imaging (SPRi) technology. SPR is the recognized golden standard for obtaining accurate kinetic data. Because of its multiplex format and the back-and-forth flow technology for ligand deposition and sample injection, the IBIS MX96 analyses 96 (bio)molecular interactions simultaneously using very low sample volume. Saving your research department time, labor, sensors and sample. By injecting 96 analytes in series using the MX96's autosampler, almost 10,000 sensorgrams are obtained in an overnight run. Months of work can be saved and the time consuming screening for epitope discovery can be speed up dramatically. Especially for the applications as epitope discovery, affinity ranking and cell interaction studies, the IBIS MX96 has proven its success at large pharmaceutical companies, biotech companies and universities.
Experience ยท 6 entries
All (6)
Investments (4)
Founder (1)
Board (1)
2018
Shareholder
Apr 2018
CryoSol-World (CryoSol) is an innovative high-tech company that aims to become the global leader in sample preparation technology for cryo-EM. At CryoSol, we believe innovation in sample preparation technology is of vital importance for structural biologists to advance their cryo-electron microscopy (cryo-EM) results. This is why our focus is on controllable and reproducible solutions. Our unique VitroJet solution helps structural biologists unravel the mysteries of proteins: the molecules of life. Proteins play a key role in developing life-changing medicines, vaccines, and cures for diseases, like COVID-19 and cancer. It will take a lot of research, knowledge-sharing and hard work to get there. That is why we are driven to help structural biologists with their challenges to vitrify samples at high throughput. We are passionate about science and we like to push the boundaries of technology. We are a flexible, open-minded team that thrives on sharing knowledge. We value the contributions of customers, partners, and colleagues around the world. Together, we can help life scientists in their quest to achieve more groundbreaking research discoveries that will make a lasting difference in life. Because two achieve more.
2005
MCH+ B.V.
boardmember / shareholder
2005
2002
CVNN
boardmember / co-founder
2002
2000
Bax & Willems Consulting Venturing
partner
2000
1999
shareholder
1999
IBIS Technologies is a leader in innovative label-free analytical systems for profiling biomolecular interactions using Surface Plasmon Resonance imaging (SPRi) technology. SPR is the recognized golden standard for obtaining accurate kinetic data. Because of its multiplex format and the back-and-forth flow technology for ligand deposition and sample injection, the IBIS MX96 analyses 96 (bio)molecular interactions simultaneously using very low sample volume. Saving your research department time, labor, sensors and sample. By injecting 96 analytes in series using the MX96's autosampler, almost 10,000 sensorgrams are obtained in an overnight run. Months of work can be saved and the time consuming screening for epitope discovery can be speed up dramatically. Especially for the applications as epitope discovery, affinity ranking and cell interaction studies, the IBIS MX96 has proven its success at large pharmaceutical companies, biotech companies and universities.
Show all 6 entries โ†“
Investment activity
1991โ€“2018 ยท 5 investments
1991119991200212005120181
Recent (last 2 years)Earlier
Investor lists
Lists that match Wilbert's portfolio